Natural Products as Sources of Antimalarial DrugsView this Special Issue
Review Article | Open Access
Exploring Antimalarial Herbal Plants across Communities in Uganda Based on Electronic Data
Malaria is one of the most rampant diseases today not only in Uganda but also throughout Africa. Hence, it needs very close attention as it can be severe, causing many deaths, especially due to the rising prevalence of pathogenic resistance to current antimalarial drugs. The majority of the Ugandan population relies on traditional herbal medicines for various health issues. Thus, herein, we review various plant resources used to treat malaria across communities in Uganda so as to provide comprehensive and valuable ethnobotanical data about these plants. Approximately 182 plant species from 63 different plant families are used for malaria treatment across several communities in Uganda, of which 112 plant species have been investigated for antimalarial activities and 96% of the plant species showing positive results. Some plants showed very strong antimalarial activities and could be investigated further for the identification and validation of potentially therapeutic antimalarial compounds. There is no record of an investigation of antimalarial activity for approximately 39% of the plant species used for malaria treatment, yet these plants could be potential sources for potent antimalarial remedies. Thus, the review provides guidance for areas of further research on potential plant resources that could be sources of compounds with therapeutic properties for the treatment of malaria. Some of the plants were investigated for antimalarial activities, and their efficacy, toxicity, and safety aspects still need to be studied.
Malaria, a dangerous and life-threatening disease caused by Plasmodium parasites is spread to humans through bites of infected female Anopheles mosquitoes . It is one of the most widespread diseases today not only in Uganda but also throughout Africa. Hence, careful monitoring of malaria is required as the disease can be severe and can cause many deaths, especially due to the increasing prevalence of resistance to current antimalarial drugs. Among the five parasitic species that cause malaria to humans, Plasmodium falciparum and Plasmodium vivax are the deadliest [2, 3]. P. falciparum and P. vivax being the most prevalent malaria parasites in sub-Saharan Africa and regions of the Americas, respectively, were responsible for about 99.7% and 74.1% of malaria cases in 2017 . In Southeast Asia, Plasmodium knowlesi is the most common cause of malaria, accounting for up to 70% of malaria cases, although it has been known to infect Old-World monkeys more . Two other species of Plasmodium, Plasmodium malariae and Plasmodium ovale, generally cause mild fevers. Approximately 216 million malaria cases were registered in 2016, with a death toll of up to 445,000 . According to the World Health Organization , the incidence of malaria in Uganda, at 47.8%, was the highest worldwide in 2005. According to Njoroge and Bussman , malaria is responsible for one to two million deaths annually in Africa. Typical symptoms of malaria include high fever, fatigue, headache, muscle ache, nausea, abdominal discomfort, and profuse sweating. However, in extreme cases and cases of prolonged illness without treatment, brain tissue injury, pulmonary edema, kidney failure, severe anemia, yellow discoloration of the skin, and low blood sugar may be noted (Figure 1) [1, 2]. In Uganda, malaria is one of the major causes of illness and death . Statistically, it accounts for 46% of children’s sicknesses, almost 40% of outpatient visits to hospitals and clinics, 25% of hospital admissions, 14% of inpatient deaths, and approximately 23% of infant mortalities .
In different parts of the world, the use of herbs and herbal extracts in the management and treatment of malaria is very common since herbs are cheap and readily available besides being effective. In fact, the use of herbal medicine for treatment worldwide is on the rise. Over 80% of the Ugandan population relies directly on herbal plants for their health care primarily . A great majority of the population uses traditional herbal medicines because of their confirmed therapeutic value . The increase in preference for herbal remedies coupled with resistance exhibited by pathogenic strains, including Plasmodium species, to the modern drugs available is the driving force behind researchers’ interest in herbal plants for possible alternatives for more effective antimalarial drugs [9, 10].
This review was aimed at providing comprehensive ethnobotanical information about various plant resources with antimalarial properties that are primarily used to manage and treat malaria across communities in Uganda, based on which further evaluation of these plants such as those of their efficacy and safety for the treatment of malaria may be based.
2. Methods and Materials
In the review, the data search processes employed by Komakech et al.  were modified to gather information on herbal plants for malaria treatment in Uganda from peer-reviewed articles in English published in scientific journals and other verifiable databases, with a focus on plant species and families, plant parts used, antimalarial activities of the extracts from herbal plants, and mechanisms of action of novel antimalarial phytochemicals and derivatives. Electronic literature databases such as PubMed, Medline, Scopus, SciFinder, Google Scholar, and Science Direct were carefully searched for suitable information. The following words were used as key search terms: (“Herbal medicine in Uganda” OR “Herbs in Uganda” OR “Traditional remedies in Uganda” OR “Natural remedies in Uganda” OR “Anti-malarial herbs in Uganda” OR “Anti-malarial plants in Uganda” OR “Ugandan herbs” OR “Ugandan ethno-medicine” OR “Ugandan phyto-medicine”), AND (“anti-plasmodial activities” OR “anti-malarial activities” OR “anti-plasmodial effects” OR “anti-malarial effects” OR “malaria treatment” OR “malaria management”) OR (“Malaria in Uganda” AND “prevalence” OR “occurrence” OR “distribution” OR “herbal treatment” OR “herbal remedies” OR “phyto-medicine” OR “phyto remedy” OR “plant parts used for treatment”) OR (Phytochemicals for malaria treatment OR Artemisinins OR Quinine OR Noble anti-malarial compounds OR Plant derived anti-malarial compounds AND mechanisms of action OR modes of action) OR (“Malaria herbal medicine in Uganda” OR “Herbal medicine in Uganda” OR “Herbal malaria remedy in Uganda” OR “Natural malaria medicine in Uganda” OR “Traditional malaria herbal medicine” OR “Malaria herbal recipe” AND “dosage” OR “dose” OR “dose given” OR “mode of administration” OR “means of traditional extraction” OR “traditional extraction” OR “Toxicity” OR “Safety and toxicity” OR “Policy framework” OR “other ethno-pharmacological uses” OR “other ethno-pharmacological utilizations” OR “other ethno-medicinal uses”). The information gathered was verified separately for its reliability; any discrepancies discovered were resolved by discussions between the authors. Thereafter, these data were summarized and analyzed, and comparisons were made to draw conclusions.
3. Prevalence of Malaria
Malaria in Uganda is highly endemic because the climate is favorable for its consistently stable and year-round transmission in about 99% of the country, with the country’s entire population being at risk for contraction . The most vulnerable groups of people at great risk for malaria are expectant mothers and young children under the age of 5 years . The malarial parasite, P. falciparum, is most commonly the cause of malaria throughout Uganda, accounting for over 90% of malaria cases. However, Betson et al.  have warned of the potential for the emergence of infections due to P. malariae and P. ovale spp. as well, since there is much focus on countering P. falciparum infections. In 2016, Larocca et al.  indicated that Uganda was one of the leading countries in the world with malaria incidence rate as high as 478 cases per 1,000 population per year. Specifically, overall registered death cases caused by malaria in children were between 70,000 and 100,000 annually in Uganda . Tremendous effort has been made to control malaria in Uganda by the government-headed Uganda Malaria Reduction Strategic Plan and Mass Action Against Malaria. These efforts have greatly reduced the malaria burden and incidence from 272 cases per 1000 population in 2016/17 to 191 cases per 1000 population in 2017/18 . Although there has been a general reduction in the incidence of malaria, studies indicate that malaria prevalence along lakes, for example, Lake Victoria, and in remote areas of the country (villages) as well as areas closer to forests are much higher, with over 450 malaria cases per 1000 population (Figure 2) [12, 13, 15]. Communities around lakeshores in Uganda have always had high prevalence of malaria among children and especially the young ones despite routine treatments [12, 16]. Through the government initiative to control malaria, the prevalence in some districts remained as low as 4.3% in 2018 . Malaria control strategies including indoor residual spraying along with house to house distribution of mosquito nets treated with insecticides resulted in a remarkable reduction in malaria burdens in many parts of the country . Raouf et al.  observed that significant reductions in the levels of malaria in Uganda cannot be sustained if the current control measures are terminated.
4. Mechanisms of Actions of Novel Phytochemicals in Malaria Treatment
Herbal plants are extremely rich in phytochemicals that are highly efficacious in the treatment of malaria, such as sesquiterpenes and sesquiterpene lactones, fluoroquinolones, chalcones, flavanones, phenolics, quinones, coumarins, and alkaloids (Table 1) [35, 36]. The herbal plants that are used as prophylactic measures to prevent malaria as well contain some of these compounds (Table 2). From these groups of compounds, active metabolites including quinine and artemisinin have been derived and the most successful antimalarial drugs to date have been obtained. Artemisinins from Artemisia annua a plant belonging to the family Asteraceae have actually been an integral part of the fight against malaria, with artemisinin-based combination therapy contributing enormously to modern day treatments . They have been effective against all strains of P. falciparum including multi-drug-resistant ones [36, 37].
The mechanism of action of artemisinin is widely debated but the most accepted theory is that of activation of the molecule by heme, which enables it to produce free radicals that then destroy the proteins needed for parasite survival . The presence of an uncommon chemical peroxide linkage bridge in artemisinin, a sesquiterpene lactone, is the most probable reason for its antimalarial effects. Cleavage of the peroxide linkage bridge in the presence of iron (II) ions (from heme) forms very reactive free radicals that undergo rapid rearrangement to form more stable carbon-centered radicals, which chemically modify the parasite and inhibit various processes within the parasite molecules, resulting in its death . Artemisinin acts on primarily the trophozoite parasitic phase and prevents disease progression. It kills circulating ring-stage parasites, thus increasing the therapeutic response . Mok et al.  suggested that artemisinin is linked to the upregulation of unfolded protein response pathways, which leads to decreased parasitic growth and development. Shandilya et al.  suggested that artemisinin is activated by iron, which then functionally inhibits PfATP6, a calcium pump, by terminating phosphorylation, nucleotide binding, and actuator domains, eventually leading to a functional loss of PfATP6 of the Plasmodium parasite and its death. A study by Mbengue et al.  indicated that artemisinin strongly inhibits phosphoinositide-3-kinase (PfPI3K), an enzyme important in cellular activities including growth, multiplication, differentiation, and survival in P. falciparum.
Cinchona tree bark, from which quinine was isolated, has been used to treat malaria since 1632 . The World Health Organization listed quinine as one of the important medicines needed in a health system . It is however only used to treat malaria caused by chloroquine-resistant strain of P. falciparum in the absence of artemisinins . A popular hypothesis about the mechanism of action of quinine is based on chloroquine, another quinoline drug which is closely linked to quinine and has been comprehensively studied. Quinine inhibits the pathway of biocrystallization of hemozoin, resulting in the accumulation of the free cytotoxic heme which eventually kills the parasite .
Most of the plants used in the treatment of malaria in Uganda contain alkaloids greatly implicated in antiplasmodial activity (Table 3). A number of alkaloids target apicoplast, an organelle in the Plasmodium parasite, while others such as benzylisoquinoline alkaloids in Cissampelos mucronata, a plant belonging to the family Menispermaceae inhibits protein synthesis in the parasite .
Flavonoids in a vast number of plants used for malaria treatment in Uganda are common to plants in the family Asteraceae such as B. longipes, A. conyzoides, and A. africana although other herbal plants from different families including C. roseus in Apocynaceae and A. zygia and A. nilotica in Mimosaceae also have them as active antiplasmodial constituents (Table 3). Flavonoids exhibit great antiplasmodial activity against different strains of the malaria parasite although the mechanism of antimalarial action is not clear . Some studies suggest that flavonoids impede the influx of myoinositol and L-glutamine in erythrocytes that are infected . Some flavonoids increase the level of oxidation of erythrocytes and inhibit protein synthesis in malaria parasites . Furthermore, flavonoids are believed to inhibit fatty acid biosynthesis (FAS II) in Plasmodium .
Artemisinin resistance in P. falciparum has been reported in Vietnam, Cambodia, Muang Lao, and Thailand. A report published in 2018 showed over 30 separate cases in Southeast Asia of artemisinin resistance . In case of resistance, parasitic clearance is slowed down and gametocytemia increases, resulting in greater selective pressure on other partner drugs to which resistance increases, thereby posing a great health threat. Thus, it is very important that the discovery of other drugs with novel mechanisms of action be prioritized by extensive exploration of the huge medicinal plant resources in Africa, which have been used by locals for effective malaria treatment yet have never been scientifically investigated for their antimalarial potential. Amoa Onguéné et al.  emphasized that it was indeed Africa’s turn to offer a new antimalarial drug to humanity since artemisinin was discovered in Asia and quinine in Latin America.
5. Herbs and Plant Parts Used to Manage and Treat Malaria across Communities in Uganda
About 182 plant species from about 63 different plant families are used to treat malaria across several communities in Uganda (Table 1). Of the 63 plant families, species within the family Asteraceae are most widely used in the country to treat malaria, constituting up to 15% of all plant species used (Figure 3(a)). This is followed by species from Fabaceae (9%), Lamiaceae (8%), Euphorbiaceae (6%), and Mimosaceae (4%) families, with Myrtaceae, Aloeaceae, and Rutaceae families each contributing approximately 3% to the total number of species used for malaria treatment in Uganda (Figure 3(a)). The remaining families contribute only 49% of the total plant species used for malaria treatment (Figure 3(a)).
The plant parts greatly used to treat malaria are leaves (54.4%) followed by roots (17.4%) and bark (16%); whole plants and other plant parts are used less commonly (Figure 3(b)). A particular herbal plant is commonly used singly though some times in combination with other herbs. The most common way of use is by boiling the medicinal plant part in water and then drinking the decoction; ingestion of fresh extracts and powdered forms of the herbs is also practiced (Table 1).
Different herbal remedies are used in different communities in different parts of the country depending on the geographical distribution of the medicinal plant species, for example, Warburgia ugandensis is particularly used in the eastern part of Uganda. However, herbal plant species such as Bidens pilosa L. are spread throughout the country and thus well known for malaria treatment across the country. In a study conducted by Ssegawa and Kasenene , no tree species in the forests of southern Uganda were more useful than Hallea rubrostipulata and Warburgia ugandensis in the treatment of malaria. These medicinal plants are known by different local names in different parts of the country as Uganda has diverse ethnic groups, including the Luo, Baganda, Itesots, and Banyankole/Bakiga.
Among all communities in Uganda, some measures are taken to control malaria, including draining of stagnant water, clearing and burning bushes, sleeping under insecticide-treated mosquito nets, and house spraying with insecticides.
6. Mode of Preparation and Use of Herbs in Treatment of Malaria in Uganda
The mode of preparation and use of herbs among different communities vary depending on the nature of the herb and plant parts used for malaria treatment . Most commonly, the herbal medicines are prepared as water extracts in the form of decoction and infusion or as steam baths (Table 1) [19, 23]. The herbal plant water extract is made mostly by boiling a handful of the medicinal plant parts such as leaves in a litre of water and then given to the patient to take orally (Table 1) . The dose of the extract given is dependent on the age of the patient and the “strength” of the herbal medicine although occasionally the weight of the patient [19, 23]. The quantity of extract given ranges from 100 to 500 ml, 100 to 250 ml, and 1 to 3 tea or tablespoons for adults, older children, and young children below 5 years of age, respectively, between 1 and 3 times a day for about a week or until when patient has recovered [19, 25]. The extracts are mostly prepared from single herbal plants or from combination of two herbal plants, for example, a decoction of Tamarindus indica and Mangifera indica is common .
In some cases, the medicinal plant parts are dried then pulverized to powder and 2–5 tablespoons of the power added to water and boiled to make a decoction. Some medicinal plant parts such as bark of M. indica stem and roots of V. lasiopus and their powders are boiled for long until the water is half the initial amount . The herbal plant powder can also be added to cold or hot water and stirred and then drunk as recommended .
Medicine for malaria treatment from a herb such as B. pilosa can be made by squeezing a handful of its freshly picked leaves and drinking 1–3 teaspoons of the extract a day (Table 1) . Occasionally, malaria herbal medicines can be obtained by preparing different plant parts in combination, for example, an infusion can be made from fresh leaves and pounded fresh roots of V. amygdalina . This is then taken orally in a recommended dose. A handful of medicinal plant parts such as leaves can be squeezed and mixed with cold or warm water for bath, for example, leaves of B. adoensis . Some common herbs are also eaten as vegetables as a prophylactic measure against malaria while others are planted in pots around houses or burnt to drive away mosquitoes (Table 2).
7. Antimalarial Activities and Toxicity of Herbs Used in Uganda for Malaria Treatment
Some studies have been performed on antiplasmodial/antimalarial activities of some of the herbal plants used in Uganda to treat malaria by using various strains of malarial parasites to confirm effectiveness as malaria treatment [26, 28]. Furthermore, a broad range of phytochemicals responsible for biological activities in some of the antimalarial herbs have been isolated and identified . Of the 182 plant species used in Uganda for the treatment of malaria, 112 plant species (64%) have been investigated for antimalarial activities, of which 108 plants showed positive results and only four plant species did not give positive results when tested for antimalarial activities (Table 1). For about 70 plant species (39%) that are used among different communities in Uganda for the treatment of malaria, there was no record of investigation for antimalarial activities (Table 1).
The antimalarial activity of herbal plants is due to the presence of a number of metabolically active compounds . These compounds may occur in the form of alkaloids, sesquiterpenes, quinones, triterpenoids, flavonoids, quassinoids, limonoids, terpenes, chalcones, coumarins, or other miscellaneous forms . The solvent of extraction largely determines the concentrations of the active metabolites in the extract. For example, methanolic extracts of the herbal plants are in general more active in vitro than water extracts probably due to the presence of higher amounts of more active lipophilic compounds (Table 3) .
The levels of activity of the antimalarial plant extracts depend on the concentration of the active antimalarial secondary metabolites . For example, gedunin, a very active compound against Plasmodium present in leaves of A. indica had an IC50 of 0.02 μg/ml against P. falciparum, but its concentration in the plant is in very low and thus moderate activity of its extract (Table 3) [23, 54].
The synergistic effect of the interaction of the different active secondary metabolites is a main contributing factor to the high levels of antiplasmodial activity of some of the herbal plant extracts, for example, in A. afra, none of the isolated flavonoids and sesquiterpenes had a high activity, yet the plant extract had an IC50 of 3.9 μg/ml against P. falciparum suggesting a synergistic effect of the compounds in the extract . The presence of particular active compounds in the herbal plant extracts is key in enhancing its antimalarial property. The compound 6E-geranylgeraniol-19-oic-acid a diterpene isolated from M. pyrifolia aqueous extract was considered responsible for its antiplasmodial activity; nitidine isolated from Z. chalybeum had an IC50 as low as 0.17 μg/ml against P. falciparum 3D7 ; and pristimerin with an IC50 0.5 mg/ml against P. falciparum was the main active ingredient in M. senegalensis extract, making it have a very high antiplasmodial activity . The presence of a moderate amount of a minimum of two secondary metabolites in the extract could explain the efficacy of the herbal extracts for malaria treatment . The pathogenic strains used may be different for different in vitro studies; thus, resistance of the parasite to the active metabolites could cause a variation in the level of antimalarial activity of the extracts . Herbal plants with no antiplasmodial activity suggest the absence of the metabolically active compounds against the Plasmodium parasites in their extracts . Table 4 indicates a list of herbal plants used for malaria treatment in Uganda with high antiplasmodial activities (IC50 μg/ml in one of its solvent extracts or high percentage inhibition of plasmodia) that could be potentially investigated further.
Although herbs are generally considered safer when used for treatment compared to conventional drugs, some of the herbs used traditionally to treat malaria in Uganda may be efficacious, but there is a need to have them used with caution as some may be toxic (Table 4). There is a variation in degree of toxicity depending on the sensitivity of animals, tissue or cells used, type of extract, nature of the test substance, dose, and mode of administration . According to Lacroix et al.  one third of the herbs for malaria treatment in Uganda they investigated had significant antiplasmodial activity with low toxicity. Some of the plant parts with good antiplasmodial/antimalarial activities with no or low toxicity include leaves of A. annua, leaves of A. africana, S. pinnata whole plant, leaves of C. papaya, and leaves of F. virosa amongst others (Table 4). There are however extracts of some plants used for malaria treatment with very good activity against Plasmodium but with high toxicity; such plant extracts include petroleum ether leaf extract of V. amygdalina and dichloromethane leaf extract of M. pyrifolia (Table 4) [32, 55]. Clerodendrum rotundifolium is on those plants that have very good antimalarial/antiplasmodial activities but have not been investigated for their toxicity (Table 4) .
8. Traditional Health Care Practice and Policy Framework in Uganda
The health care system of Uganda consists of the public, private-profit oriented, and private-nonprofit oriented sectors. There is quite a large sector of informal health care including traditional medicine practitioners, drug shops, medicine vendors, and complementary and alternative practitioners. The contribution of traditional health practitioners to Uganda’s health care system was not valued until lately . The negative perspective could be traced back to the colonial times when culture including use of traditional medicine such as herbs for treatment was considered primitive and so discouraged . Efforts are now being made to promote the use of traditional medicine since the government has realized that traditional health practitioners are key contributors to its primary health care system . The Ministry of Health created a public-private partnership with the traditional health practitioners following a recommendation that they be brought into the mainstream health system [115, 116].
A policy on Traditional and Complementary Medicine was created to regulate traditional medicine practice focusing on research and development while emphasizing the propagation, protection, and sustainable use of medicinal plant resources [115, 116]. For collaboration between the mainstream health care sector and traditional health practitioners, the Ministry of Health submitted a bill for the creation of the National Council of Indigenous and Complementary Medicine Practitioners, a semiautonomous body that shall as well protect their intellectual property rights [115, 116].
The National Drug Authority (NDA) is a body that ensures quality control of all medical products including herbal medicines in Uganda under the government statute and policy of 1993 . In Uganda, there is no special regulatory measure for herbal medicines in that the same laws and policies for conventional pharmaceuticals also apply to the herbal medicinal products. A policy was introduced in 2002 to have herbal medicines registered, but so far, no registration of any herbal medicine has been made .
Herbal medicines though vastly used in Uganda are not sufficiently regulated. A system to license and track traditional health practitioners or their products is still lacking in the country, and the efforts to have the TCM integrated in the mainstream health care system is still a long way from being realized.
Uganda is rich in indigenous plant resources that are used by its people to treat malaria. Communities in different regions of the country use different herbs within their geographical range, though a few common herbs are used by different communities across the country. Many herbs used for malaria treatment among several communities have not been investigated for their efficacy, and yet they could be potential sources for antimalarial remedies including drugs. Few studies have been conducted to document herbs for malaria treatment in the country, especially in the northern region. Some of the plants investigated for antimalarial/antiplasmodial activities have been found to lack efficacy, toxicity, and safety study aspects. Some plants used in the local communities had very strong antimalarial activities and could be investigated further for the identification and validation of the potential therapeutic antimalarial compounds. This review is critical in that it clearly highlights herbal plants documented in Uganda for malaria treatment but have never been investigated for their antimalarial potential, thus providing guidance for further research on potential natural plant resources that could be sources of novel compounds with therapeutic properties for the treatment of malaria.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Denis Okello carried out the data search and was the main contributor in writing the manuscript. Youngmin Kang technically designed and helped in writing the manuscript. Both authors read and approved the final manuscript.
This study was supported under the framework of International Cooperation Program (Korea-South Africa Cooperative Research Project for Excavation of Candidate Resources of Complementary and Alternative Medicine) managed by National Research Foundation of Korea (grant nos. 2017093655 and KIOM:D17470). Additionally, this study was equally supported by grants from Development of Foundational Techniques for the Domestic Production of Herbal Medicines (K18405) and Applicational Development of Standardized Herbal Resources (KSN1911420), from the Korea Institute of Oriental Medicine (KIOM), through the Ministry of Science and ICT, Republic of Korea.
- World Health Organisation, World Malaria Report 2017, World Health Organisation, Geneva, Switzerland, 2017.
- W. H. Pan, X. Y. Xu, N. Shi, S. W. Tsang, and H. J. Zhang, “Antimalarial activity of plant metabolites,” International Journal of Molecular Sciences, vol. 19, no. 5, p. 1382, 2018.
- V. Asua, L. Mugenyi, P. J. Rosenthal et al., “Plasmodium species infecting children presenting with malaria in Uganda,” The American Journal of Tropical Medicine and Hygiene, vol. 97, no. 3, pp. 753–757, 2017.
- World Health Organisation, World Malaria Report 2018, World Health Organisation, Geneva, Switzerland, 2018.
- B. E. Barber, M. J. Grigg, T. William, T. W. Yeo, and N. M. Anstey, “The treatment of plasmodium knowlesi malaria,” Trends in Parasitology, vol. 33, no. 3, pp. 242–253, 2017.
- World Health Organisation, World Malaria Report 2005, World Health Organisation, Geneva, Switzerland, 2005.
- G. Njoroge and R. Bussmann, “Diversity and utilization of antimalarial ethnophytotherapeutic remedies among Kikuyus (Central Kenya),” Journal of Ethnobiology and Ethnomedicine, vol. 2, no. 1, p. 8, 2006.
- P. Tugume, E. K. Kakudidi, M. Buyinza et al., “Ethnobotanical survey of medicinal plant species used by communities around Mabira Central forest reserve, Uganda,” Journal of Ethnobiology and Ethnomedicine, vol. 12, no. 1, p. 5, 2016.
- S. Sharafzadeth and O. Alizadeti, “Some medicinal plants cultivated in Iran,” Journal of Applied Pharmaceutical Science, vol. 2, no. 1, pp. 134–137, 2012.
- M. M. Adia, G. Anywar, R. Byamukama et al., “Medicinal plants used in malaria treatment by prometra herbalists in Uganda,” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 580–588, 2014.
- R. Komakech, Y. Kang, J.-H. Lee, and F. Omujal, “A review of the potential of phytochemicals from prunus africana (hook f.) kalkman stem bark for chemoprevention and chemotherapy of prostate cancer,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 3014019, 10 pages, 2017.
- Uganda Ministry of Health, National Malaria Annual Report 2017-2018, National Malaria Control Dividion, Surveillance Monitoring and Evaluation Unit, Uganda Ministry of Health, Kampala, Uganda, 2019.
- M. Betson, S. Clifford, M. Stanton, N. B. Kabatereine, and J. R. Stothard, “Emergence of nonfalciparum plasmodium infection despite regular artemisinin combination therapy in an 18-month longitudinal study of Ugandan children and their mothers,” The Journal of Infectious Diseases, vol. 217, no. 7, pp. 1099–1109, 2018.
- A. Larocca, R. Moro Visconti, and M. Marconi, “Malaria diagnosis and mapping with M-health and geographic information systems (GIS): evidence from Uganda,” Malaria Journal, vol. 15, no. 1, p. 520, 2016.
- B. Donnelly, L. Berrang-Ford, J. Labbe et al., “Plasmodium falciparum malaria parasitaemia among indigenous batwa and non-indigenous communities of Kanungu district, Uganda,” Malaria Journal, vol. 15, no. 1, p. 254, 2016.
- M. Betson, J. C. Sousa-Figueiredo, A. Atuhaire et al., “Detection of persistent plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment,” Parasitology, vol. 141, no. 14, pp. 1880–1890, 2014.
- D. W. Oguttu, J. K. B. Matovu, D. C. Okumu et al., “Rapid reduction of malaria following introduction of vector control interventions in Tororo district, Uganda: a descriptive study,” Malaria Journal, vol. 16, no. 1, p. 227, 2017.
- S. Raouf, A. Mpimbaza, R. Kigozi et al., “Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in an area of Uganda with previously high-transmission intensity,” Clinical Infectious Diseases, vol. 65, no. 3, pp. 453–460, 2017.
- T. Strangeland, P. E. Alele, E. Katuura, and K. A. Lye, “Plants used to treat malaria in Nyakayojo sub-county, Western Uganda,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 154–166, 2011.
- P. Ssegawa and J. M. Kasenene, “Plants for malaria treatment in Southern Uganda: traditional use, preference and ecological viability,” Journal of Ethnobiology, vol. 27, no. 1, pp. 110–131, 2007.
- J. R. Tabuti, “Herbal medicines used in the treatment of malaria in budiope county, Uganda,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 33–42, 2008.
- I. E. Cock, “The genus aloe: phytochemistry and therapeutic uses including treatments for gastrointestinal conditions and chronic inflammation,” Progress in Drug Research, Arthritis and Gastro-Intestinal Diseases, vol. 70, pp. 179–235, 2015.
- K. Philip, M. Elizabeth, P. Cheplogoi, and K. Samuel, “Ethnobotanical survey of antimalarial medicinal plants used in Butebo county, Eastern Uganda,” European Journal of Medicinal Plants, vol. 21, no. 4, pp. 1–22, 2017.
- E. Katuura, P. Waako, J. Ogwal-Okeng, and R. Bukenya-Ziraba, “Traditional treatment of malaria in Mbarara district, Western Uganda,” African Journal of Ecology, vol. 45, no. 1, pp. 48–51, 2007.
- G. Anywar, C. I. E. A. van’t Klooster, R. Byamukama et al., “Medicinal plants used in the treatment and prevention of malaria in Cegere sub-county, Northern Uganda,” Ethnobotany Research and Applications, vol. 14, pp. 505–516, 2016.
- C. J. D. Obbo, S. T. Kariuki, J. W. Gathirwa, W. Olaho-Mukani, P. K. Cheplogoi, and E. M. Mwangi, “In vitro antiplasmodial, antitrypanosomal and antileishmanial activities of selected medicinal plants from Ugandan flora: refocusing into multi-component potentials,” Journal of Ethnopharmacology, vol. 229, pp. 127–136, 2019.
- D. Okello, R. Komakech, M. G. Matsabisa, and Y.-M. Kang, “A review on the botanical aspects, phytochemical contents and pharmacological activities of Warburgia ugandensis,” Journal of Medicinal Plants Research, vol. 12, no. 27, pp. 448–455, 2018.
- M. M. Adia, S. N. Emami, R. Byamukama, I. Faye, and A.-K. Borg-Karlson, “Antiplasmodial activity and phytochemical analysis of extracts from selected Ugandan medicinal plants,” Journal of Ethnopharmacology, vol. 186, pp. 14–19, 2016.
- F. W. Muregi, S. C. Chhabra, E. N. Njagi et al., “In vitro antiplasmodial activity of some plants used in Kisii, Kenya against malaria and their chloroquine potentiation effects,” Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 235–239, 2003.
- M. M. Kamatenesi, A. Acipa, and H. Oryem-Origa, “Medicinal plants of Otwal and Ngai sub counties in Oyam district, Northern Uganda,” Journal of Ethnobiology and Ethnomedicine, vol. 7, no. 1, p. 7, 2011.
- J. R. Tabuti, C. B. Kukunda, D. Kaweesi, and O. M. Kasilo, “Herbal medicine use in the districts of Nakapiripirit, Pallisa, Kanungu, and Mukono in Uganda,” Journal of Ethnobiology and Ethnomedicine, vol. 8, no. 1, p. 35, 2012.
- D. Lacroix, S. Prado, D. Kamoga et al., “Antiplasmodial and cytotoxic activities of medicinal plants traditionally used in the village of Kiohima, Uganda,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 850–855, 2011.
- H. Kaur, H. M. Mukhtar, A. Singh, and A. Mahajan, “Antiplasmodial medicinal plants: a literature review on efficacy, selectivity and phytochemistry of crude plant extracts,” Journal of Biologically Active Products from Nature, vol. 8, no. 5, pp. 272–294, 2018.
- R. K. Nanyunja, Indigenous Knowledge of the Abundance of Medicinal and Food Plants in Mount Moroto Forest Reserve, Institute of Environmental & Natural Resources, Makerere University, Kampala, Uganda, 2003.
- P. Amoa Onguéné, F. Ntie-Kang, L. Lifongo, J. Ndom, W. Sippl, and L. Mbaze, “The potential of anti-malarial compounds derived from african medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids,” Malaria Journal, vol. 12, no. 1, p. 449, 2013.
- E. G. Tse, M. Korsik, and M. H. Todd, “The past, present and future of anti-malarial medicines,” Malaria Journal, vol. 18, no. 1, p. 93, 2019.
- S. Krishna, A. C. Uhlemann, and R. K. Haynes, “Artemisinins: mechanisms of action and potential for resistance,” Drug Resistance Updates, vol. 7, no. 4-5, pp. 233–244, 2004.
- S. Mok, K.-Y. Liong, E.-H. Lim et al., “Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs,” Molecular Microbiology, vol. 91, no. 5, pp. 918–934, 2014.
- A. Shandilya, S. Chacko, B. Jayaram, and I. Ghosh, “A plausible mechanism for the antimalarial activity of artemisinin: a computational approach,” Scientific Reports, vol. 3, no. 1, p. 2513, 2013.
- A. Mbengue, S. Bhattacharjee, T. Pandharkar et al., “A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria,” Nature, vol. 520, no. 7549, pp. 683–687, 2015.
- H. M. Staines and S. Krishna, Treatment and Prevention of Malaria, Springer, Basel, Switzerland, 2012.
- World Health Organization, Model List of Essential Medicines, 19th List, World Health Organization, Geneva, Switzerland, 2015.
- E. Esu, E. E. Effa, O. N. Opie, A. Uwaoma, and M. M. Meremikwu, “Artemether for severe malaria (Review),” The Cochrane Database of Systematic Reviews, vol. 9, no. 9, Article ID CD010678, 2014.
- M. Foley and L. Tilley, “Quinoline antimalarials: mechanisms of action and resistance,” International Journal for Parasitology, vol. 27, no. 2, pp. 231–240, 1997.
- S. Bbosa, D. B. Kyegombe, A. Lubega, N. Musisi, J. Ogwal-Okeng, and O. Odyek, “Anti-Plasmodium falciparum activity of Aloe dawei and Justicia betonica,” African Journal of Pharmacy and Pharmacology, vol. 7, no. 31, pp. 2258–2263, 2013.
- E. V. M. Kigondu, G. M. Rukunga, J. M. Keriko et al., “Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya,” Journal of Ethnopharmacology, vol. 123, no. 3, pp. 504–509, 2009.
- B. O. Owuor, J. O. Ochanda, J. O. Kokwaro et al., “In vitro antiplasmodial activity of selected luo and kuria medicinal plants,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 779–781, 2012.
- K. A. Shah, M. B. Patel, R. J. Patel, and P. K. Parmar, “Mangifera indica (mango),” Pharmacognosy Reviews, vol. 4, no. 7, pp. 42–48, 2010.
- A. Asase, G. A. Akwetey, and D. G. Achel, “Ethnopharmacological use of herbal remedies for the treatment of malaria in the Dangme West district of Ghana,” Journal of Ethnopharmacology, vol. 129, no. 3, pp. 367–376, 2010.
- K. Murugan, N. Aarthi, K. Kovendan et al., “Mosquitocidal and antiplasmodial activity of Senna occidentalis (cassiae) and ocimum basilicum (lamiaceae) from Maruthamalai hills against Anopheles stephensi and Plasmodium falciparum,” Parasitology Research, vol. 114, no. 10, pp. 3657–3664, 2015.
- E. T. Idowu, H. C. Ajaegbu, A. I. Omotayo, O. O. Aina, and O. A. Otubanjo, “In vivo anti-plasmodial activities and toxic impacts of lime extract of a combination of Picralima nitida, Alstonia boonei and Gongronema latifolium in mice infected with chloroquine-sensitive Plasmodium berghei,” African Health Sciences, vol. 15, no. 4, pp. 1262–1270, 2015.
- C. Clarkson, V. J. Maharaj, N. R. Crouch et al., “In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa,” Journal of Ethnopharmacology, vol. 92, no. 2-3, pp. 177–191, 2004.
- A. Fatima, P. P. Singh, P. Agarwal, R. Irchhaiya, S. Alok, and A. Verma, “Treatment of various diseases by Carissa spinarum L.–a promising shrub,” IJPSR, vol. 4, no. 7, pp. 2489–2495, 2013.
- C. N. Muthaura, J. M. Keriko, C. Mutai et al., “Antiplasmodial potential of traditional phytotherapy of some remedies used in treatment of malaria in Meru-Tharaka Nithi County of Kenya,” Journal of Ethnopharmacology, vol. 175, pp. 315–323, 2015.
- R. Muganga, L. Angenot, M. Tits, and M. Frédérich, “Antiplasmodial and cytotoxic activities of rwandan medicinal plants used in the treatment of malaria,” Journal of Ethnopharmacology, vol. 128, no. 1, pp. 52–57, 2010.
- R. Kumar, S. Duffy, V. M. Avery, and R. A. Davis, “Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid,” Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 17, pp. 4091–4095, 2017.
- M. T. Lemma, A. M. Ahmed, M. T. Elhady et al., “Medicinal plants for in vitro antiplasmodial activities: a systematic review of literature,” Parasitology International, vol. 66, no. 6, pp. 713–720, 2017.
- A. G. Christian, A. G. Mfon, E. A. Dick, E. David-Oku, A. J. Linus, and E. B. Chukwuma, “Antimalarial potency of the leaf extract of Aspilia africana (Pers.) C.D. Adams,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 2, pp. 126–129, 2012.
- R. Nondo, M. Moshi, P. Erasto et al., “Evaluation of the cytotoxic activity of extracts from medicinal plants used for the treatment of malaria in Kagera and Lindi regions, Tanzania,” Journal of Applied Pharmaceutical Science, vol. 5, no. 4, pp. 007–012, 2015.
- J. E. Okokon, B. S. Antia, D. Mohanakrishnan, and D. Sahal, “Antimalarial and antiplasmodial activity of husk extract and fractions of zea mays,” Pharmaceutical Biology, vol. 55, no. 1, pp. 1394–1400, 2017.
- G. Zemicheal and Y. Mekonnen, “Antiplasmodial activity of Vernonia adoensis aqueous, methanol and chloroform leaf extracts against chloroquine sensitive strain of Plasmodium berghei in vivo in mice,” BMC Research Notes, vol. 11, no. 1, p. 736, 2018.
- A. Soma, S. Sanon, A. Gansane et al., “Antiplasmodial activity of Vernonia cinerea Less (Asteraceae), a plant used in traditional medicine in burkina faso to treat malaria,” African Journal of Pharmacy and Pharmacology, vol. 11, no. 5, pp. 87–93, 2017.
- W. Ekasari, T. S. Wahyuni, H. Arwaty, and N. T. Putri, “Determination of effective dose of antimalarial from cassia spectabilis leaf ethanol extract in plasmodium berghei-infected mice,” African Journal of Infectious Diseases, vol. 12, no. 1S, pp. 111–115, 2018.
- G. K. Mesia, G. L. Tona, T. H. Nanga et al., “Antiprotozoal and cytotoxic screening of 45 plant extracts from Democratic Republic of Congo,” Journal of Ethnopharmacology, vol. 115, no. 3, pp. 409–415, 2008.
- P. Melariri, W. Campbell, P. Etusim, and P. Smith, “Antiplasmodial properties and bioassay-guided fractionation of ethyl acetate extracts from carica papaya leaves,” Journal of Parasitology Research, vol. 2011, Article ID 104954, 7 pages, 2011.
- M. O. Nanyingi, K. B. Kipsengeret, C. G. Wagate, B. K. Langat, L. L. Asaava, and J. O. Midiwo, “In vitro and in vivo antiplasmodial activity of Kenyan medicinal plants.,” in Aspects of African Biodiversity: Proceedings of the Pan-Africa Chemistry Network, J. O. Midiwo and J. Clough, Eds., pp. 20–28, RCS Publishing, Cambridge, UK, 2010.
- D. N. Cysne, T. S. Fortes, A. S. Reis et al., “Antimalarial potential of leaves of Chenopodium ambrosioides L,” Parasitology Research, vol. 115, no. 11, pp. 4327–4334, 2016.
- K. Asres, F. Bucar, E. Knauder, V. Yardley, H. Kendrick, and S. L. Croft, “In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle,” Phytotherapy Research, vol. 15, no. 7, pp. 613–617, 2001.
- C. Z. Amorim, A. D. Marques, and R. S. B. Cordeiro, “Screening of the antimalarial activity of plants of the cucurbitaceae family,” Memórias Do Instituto Oswaldo Cruz, vol. 86, no. suppl 2, pp. 177–180, 1991.
- P. B. Memvanga, G. L. Tona, G. K. Mesia, M. M. Lusakibanza, and R. K. Cimanga, “Antimalarial activity of medicinal plants from the Democratic Republic of Congo: a review,” Journal of Ethnopharmacology, vol. 169, pp. 76–98, 2015.
- L. Bantie, S. Assefa, T. Teklehaimanot, and E. Engidawork, “In vivo antimalarial activity of the crude leaf extract and solvent fractions of croton macrostachyus hocsht. (euphorbiaceae) against plasmodium berghei in mice,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 79, 2014.
- A. M. Kaou, V. Mahiou-Leddet, S. Hutter et al., “Antimalarial activity of crude extracts from nine african medicinal plants,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 74–83, 2008.
- O. Abiodun, G. Gbotosho, E. Ajaiyeoba et al., “In vitro antiplasmodial activity and toxicity assessment of some plants from Nigerian ethnomedicine,” Pharmaceutical Biology, vol. 49, no. 1, pp. 9–14, 2011.
- M. Mustofa, E. N. Sholikhah, and S. Wahyuono, “In vitro and in vivo antiplasmodial activity and cytotoxicity of extracts of Phyllanthus niruri L. herbs traditionally used to treat malaria in Indonesia,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 38, no. 4, pp. 609–615, 2007.
- G. Duker-Eshun, J. W. Jaroszewski, W. A. Asomaning, F. Oppong-Boachie, and S. Brogger Christensen, “Antiplasmodial constituents of Cajanus cajan,” Phytotherapy Research, vol. 18, no. 2, pp. 128–130, 2004.
- I. C. Ezenyi, L. Ranarivelo, S. A. Oluwakanyinsola, and M. Emeje, “Analgesic, anti-inflammatory, and heme biomineralization inhibitory properties of entada africana ethanol leaf extract with antiplasmodial activity against Plasmodium falciparum,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 25, no. 2, pp. 217–223, 2014.
- G. Komlaga, C. Agyare, R. A. Dickson et al., “Medicinal plants and finished marketed herbal products used in the treatment of malaria in the Ashanti region, Ghana,” Journal of Ethnopharmacology, vol. 172, pp. 333–346, 2015.
- J. M. Nguta and J. M. Mbaria, “Brine shrimp toxicity and antimalarial activity of some plants traditionally used in treatment of malaria in Msambweni district of Kenya,” Journal of Ethnopharmacology, vol. 148, no. 3, pp. 988–992, 2013.
- K. A. M. Kuria, S. De Coster, G. Muriuki et al., “Antimalarial activity of Ajuga remota benth (labiatae) and Caesalpinia volkensii harms (Caesalpiniaceae): in vitro confirmation of ethnopharmacological use,” Journal of Ethnopharmacology, vol. 74, no. 2, pp. 141–148, 2001.
- C. N. Muthaura, J. M. Keriko, C. Mutai et al., “Antiplasmodial potential of traditional antimalarial phytotherapy remedies used by the kwale community of the Kenyan Coast,” Journal of Ethnopharmacology, vol. 170, pp. 148–157, 2015.
- A. Kefe, M. Giday, H. Mamo, and B. Erko, “Antimalarial properties of crude extracts of seeds of brucea antidysenterica and leaves of Ocimum lamiifolium,” BMC Complementary and Alternative Medicine, vol. 16, p. 118, 2016.
- V. D. Zheljazkov, T. Astatkie, I. Zhalnov, and T. D. Georgieva, “Method for attaining rosemary essential oil with differential composition from dried or fresh material,” Journal of Oleo Science, vol. 64, no. 5, pp. 485–496, 2015.
- A. Kumari, P. Baskaran, J. C. Chukwujekwu, C. A. de Kock, P. J. Smith, and J. Van Staden, “The changes in morphogenesis and bioactivity of Tetradenia riparia, Mondia whitei and Cyanoptis speciosa by an aeroponic system,” Industrial Crops and Products, vol. 84, pp. 199–204, 2016.
- G. Komlaga, S. Cojean, R. A. Dickson et al., “Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana,” Parasitology Research, vol. 115, no. 8, pp. 3185–3195, 2016.
- R. Batista, A. De Jesus Silva Jr., and A. de Oliveira, “Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products,” Molecules, vol. 14, no. 8, pp. 3037–3072, 2009.
- L. Alli, A. Adesokan, and A. Salawu, “Antimalarial activity of fractions of aqueous extract of Acacia nilotica root,” Journal of Intercultural Ethnopharmacology, vol. 5, no. 2, pp. 180–185, 2016.
- B. Ndjakou Lenta, C. Vonthron-Senecheau, R. Fongang Soh et al., “In vitro antiprotozoal activities and cytotoxicity of some selected cameroonian medicinal plants,” Journal of Ethnopharmacology, vol. 111, no. 1, pp. 8–12, 2007.
- A. G. Bwalya, “Evaluation of the in vitro biological activities and phytochemical profiling of eight ficus species collected in Zambia,” University College London (UCL), School of Pharmacy, London, UK, 2014, Doctoral Thesis.
- J. O. Areola, N. O. Omisore, and O. O. Babalola, “Antiplasmodial activity of stem-bark extract of Milicia excelsa (welw.) c.c.berg against rodent malaria parasites (Plasmodium berghei) in mice,” Ife Journal of Science, vol. 18, no. 4, pp. 905–911, 2016.
- A. Bagavan, A. A. Rahuman, N. K. Kaushik, and D. Sahal, “In vitro antimalarial activity of medicinal plant extracts against Plasmodium falciparum,” Parasitology Research, vol. 108, no. 1, pp. 15–22, 2011.
- M. Ohashi, M. Amoa-Bosompem, K. D. Kwofie et al., “In vitro antiprotozoan activity and mechanisms of action of selected G hanaian medicinal plants against trypanosoma, leishmania, and plasmodium parasites,” Phytotherapy Research, vol. 32, no. 8, pp. 1617–1630, 2018.
- P. Pillay, V. J. Maharaj, and P. J. Smith, “Investigating South African plants as a source of new antimalarial drugs,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 438–454, 2008.
- C. A. Simões-Pires, S. Vargas, A. Marston et al., “Ellagic acid derivatives from Syzygium cumini stem bark: investigation of their antiplasmodial activity,” Natural Product Communications, vol. 4, no. 10, pp. 1371–1376, 2009.
- S. A. Tadesse and Z. B. Wubneh, “Antimalarial activity of Syzygium guineense during early and established plasmodium infection in rodent models,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, p. 21, 2017.
- U. M. Chukwuocha, O. Fernández-Rivera, and M. Legorreta-Herrera, “Exploring the antimalarial potential of whole Cymbopogon citratus plant therapy,” Journal of Ethnopharmacology, vol. 193, pp. 517–523, 2016.
- J. E. Okokon, E. O. Etebong, J. A. Udobang, and J. Obot, “Antiplasmodial and antiulcer activities of Melanthera scadens,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 1, pp. 16–20, 2012.
- M. Endale, J. P. Alao, H. M. Akala et al., “Antiplasmodial quinones from Pentas longiflora and Pentas lanceolata,” Planta Medica, vol. 78, no. 1, pp. 31–35, 2012.
- A. T. Khalil, G. T. Maatooq, and K. A. El Sayed, “Limonoids from Citrus reticulata,” Zeitschrift Für Naturforschung C, vol. 58, no. 3-4, pp. 165–170, 2003.
- P. Chinwuba, P. A. Akah, and E. E. Iiodigwe, “In vivo antiplasmodial activity of the ethanol stem extract and fractions of Citrus sinensis in mice,” Merit Research Journal of Medicine and Medical Sciences, vol. 3, no. 4, pp. 140–146, 2015.
- M. H. F. Haddad, H. Mahbodfar, Z. Zamani, and A. Ramazani, “Antimalarial evaluation of selected medicinal plant extracts used in Iranian traditional medicine,” Iranian Journal of Basic Medical Sciences, vol. 20, no. 4, pp. 415–422, 2017.
- Z. A. Busari, K. A. Dauda, O. A. Morenikeji et al., “Antiplasmodial activity and toxicological assessment of curcumin PLGA-encapsulated nanoparticles,” Frontiers in Pharmacology, vol. 8, p. 622, 2017.
- J. S. Freundlich, J. W. Anderson, D. Sarantakis et al., “Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4′-substituted triclosan derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 23, pp. 5247–5252, 2005.
- N. Q. Liu, F. Van Der Kooy, and R. Verpoorte, “Artemisia afra: a potential flagship for African medicinal plants?” South African Journal of Botany, vol. 75, no. 2, pp. 185–195, 2009.
- E. Yarnell, “Artemisia annua (sweet annie), other artemisia species, artemisinin, artemisinin derivatives, and malaria,” Journal of Restorative Medicine, vol. 3, no. 1, pp. 69–84, 2014.
- S. Sawadogo, S. D. Sanou, A. P. Dabiré et al., “In vivo evaluation of Jatropha curcas L (euphorbiaceae) leaves acute and subacute toxicity in mice,” Journal of Scientific Research, vol. 10, no. 2, pp. 187–193, 2018.
- W.-C. Teng, W. Chan, R. Suwanarusk et al., “In vitro antimalarial evaluations and cytotoxicity investigations of carica papaya leaves and carpaine,” Natural Product Communications, vol. 14, no. 1, pp. 33–36, 2019.
- H. M. Malebo, V. Wiketye, S. J. Katani et al., “In vivo antiplasmodial and toxicological effect of Maytenus senegalensis traditionally used in the treatment of malaria in Tanzania,” Malaria Journal, vol. 14, no. 1, p. 79, 2015.
- S. Froelich, B. Onegi, A. Kakooko, K. Siems, C. Schubert, and K. Jenett-Siems, “Plants traditionally used against malaria: phytochemical and pharmacological investigation of Momordica foetida,” Revista Brasileira de Farmacognosia, vol. 17, no. 1, pp. 1–17, 2007.
- J.-T. Banzouzi, R. Prado, H. Menan et al., “In vitro antiplasmodial activity of extracts of Alchornea cordifolia and identification of an active constituent: ellagic acid,” Journal of Ethnopharmacology, vol. 81, no. 3, pp. 399–401, 2002.
- S. V. Singh, A. Manhas, Y. Kumar et al., “Antimalarial activity and safety assessment of Flueggea virosa leaves and its major constituent with special emphasis on their mode of action,” Biomedicine & Pharmacotherapy, vol. 89, pp. 761–771, 2017.
- G. Asare, P. Addo, K. Bugyei et al., “Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri,” Interdisciplinary Toxicology, vol. 4, no. 4, pp. 206–210, 2011.
- S. O. Okpo, C. O. Igwealor, and G. I. Eze, “Sub-acute toxicity study on the aqueous extract of Albizia zygia stem bark,” Journal of Pharmacy & Bioresources, vol. 13, no. 1, pp. 32–41, 2016.
- S. Mandal and M. Mandal, “Tangerine (Citrus reticulata L. var.) oils,” in Essential Oils in Food Preservation, Flavor and Safety, pp. 803–811, Elsevier, Amsterdam, Netherlands, 2016.
- H. A. Abdelgadir and J. Van Staden, “Ethnobotany, ethnopharmacology and toxicity of Jatropha curcas L. (Euphorbiaceae): a review,” South African Journal of Botany, vol. 88, pp. 204–218, 2013.
- E. Falk, Traditional Medicine; Sharing Experiences from the Field, ICHCAP, Jeonju, Republic of Korea, 2017.
- The republic of Uganda, National Medicines Policy, Ministry of Health, Kampala, Uganda, 2015.
- R. P. Giri, A. K. Gangawane, and S. G. Giri, “Regulation on herbal product used as medicine around the world: a review,” IRJET, vol. 5, no. 10, 2018.
Copyright © 2019 Denis Okello and Youngmin Kang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.